CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

Clinical trial NCT04264143 · COMPLETED

Trial details

NCT number: NCT04264143
Sponsor: Luca Szalontay
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Pontine and Thalamic Gliomas Diffuse Midline Glioma

Start date: 2020-03-10
Primary completion: 2022-04-25
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.